Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Effects of a standardized mother-child intervention programme in adolescent mothers and their children
ISRCTN ISRCTN13962271
DOI 10.1186/ISRCTN13962271
ClinicalTrials.gov identifier
EudraCT number
Public title Effects of a standardized mother-child intervention programme in adolescent mothers and their children
Scientific title Behavioural, developmental and neural effects of a standardized mother-child intervention programme in adolescent mothers and their children
Acronym TeeMo
Serial number at source 2.0 (15/08/2012)
Study hypothesis Within a RCT design, a parental programme based on STEEP plus psychiatric treatment of the mother in case of mental illness will be compared to TAU (standardized support by the child welfare office) in adolescent, high-risk mothers. The primary outcome variables are the maternal sensitivity and the child’s well-being. Moderators of treatment outcome (e.g. child development, genotype, child temperament, neural and hormonal mechanism associated with parental bonding in the mother) as well as treatment effects in the child (cognitive and somatic development, structural brain maturation) will be systematically explored. A control goup of adult mothers will be compared with the adolescent group.
Lay summary Lay summary under review 3
Ethics approval University Hospital of Aachen, 10 September 2012, ref: 12-006
Study design Randomised controlled trial with three arms
Countries of recruitment Germany
Disease/condition/study domain Adolescent mothers
Participants - inclusion criteria 1. Child 3-6 months of age
2. Mother pregnant before 21st birthday
3. First or second child
4. Verbal intervention possilble (no language or intellectual constraint)
5. Caucasian mother
6. Mother and child live together
7. Informed consent
Participants - exclusion criteria 1. Addiction (except for nicotin)
2. Birth of the child before 35th week of pregnancy was fulfilled
3. Syndromes or severe illnesses within the child
4. Severe psychiatric illness or suicidality within the mother
5. Separation of mother and child more than 3 months
6. Another video-intervention is planned
Anticipated start date 01/10/2012
Anticipated end date 31/03/2014
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 180 adolescents and 40 adult mother-child-dyads
Interventions Three arms:
1. Adolescent intervention group
2. Adolescent treatment as usual (TAU)
3. Adult controls

The active group will take part in a programme based on the principles of STEEP when the children are at least 3 months of age. They are visited every 2 weeks by the same adviser for the duration of 9 months. The topics of the home visits will be built on the manual by Erickson/Egeland (German edition by Suess, 2009). On average mother-child dyads will receive 12-18 home visits. Every second visit a short video-documentation of mother-child interaction will be analyzed together with the mother, which has proven to be a promising tool to increase sensitive parenting. In addition, psychiatric diseases in the mother (such as depression, etc.) will be treated by a psychiatrist/psychologist if needed.
Primary outcome measure(s) 1. Maternal sensitivity score, assessed by the sensivity-scale of the Emotional Availability Scale (EAS)
2. Child’s" well-being", assessed with the EAS-Scales
3. Child’s responsiveness to the parent
4. Child’s involvement of the parent

There will be three appointments: first one at the beginning of the intervention right after the inclusion, next one after intervention (9 months after inclusion) and the last one 6 months after the end of intervention (15 Months after inclusion). TAU and the adult control group will be assessed with parallel appointments.
Secondary outcome measure(s) 1. BIS-15 Barratt Impulsiveness Scale
2. BDI-II Becks Depression Inventory, Second Edition
3. BSDI-III Bayley Scales of Infant Development
4. CAARS Conners Adult ADHD Rating Scale
5. CAPI Child Abuse Potential Inventory (deutsche Version: EBSK)
6. CECA-Q Childhood Experiences of Care Abuse Questionnaire
7. CFT 20-R Culture Fair Intelligence Test – Scale 2, Revision
8. ECR-R Experiences in Close Relationships Scale-Revised
9. DERS Difficulties in Emotion Regulation Scale
10. IBQ-R Infant Behavior Questionnaire
11. IPDE The International Personality Disorder Examination
12. IRI; EC Interpersonal Reacivity Index
13. M.I.N.I .Mini-International Neuropsychiatric Interview
14. PSI Parental Stress Index (deutsche Version: EBI)
15. SST Strange Situation Test (deutsch FST)
16. STAI State-Trait Anxiety Inventory
17. VASQ Vulnerable Attachment Style Questionnaire
18. Analysis of fMRI-paradigms (Baby Face Incentive Delay Task and Infant Cry Self Distraction Paradigma)
Sources of funding Federal Ministry of Education and Research [BMBF] (Germany) ref: 01KR1207B
Trial website http://teemo-aachen.de
Publications
Contact name Prof  Beate  Herpertz-Dahlmann
  Address University Hospital of the Rheinisch-Westfaelische Technische Hochschule Aachen
Department of Child and Adolescent Psychiatry and Psychotherapy
Neuenhofer Weg 21
  City/town Aachen
  Zip/Postcode 52074
  Country Germany
  Tel +49 241 808 8737
  Email b.herpertzdahlmann@ukaachen.de
Sponsor Federal Ministry of Education and Research [BMBF] (Germany)
  Address Hannoversche Straße 28-30
  City/town Berlin
  Zip/Postcode 10115
  Country Germany
  Email information@bmbf.bund.de
  Sponsor website: http://www.bmbf.de/en/
Date applied 19/09/2012
Last edited 07/01/2013
Date ISRCTN assigned 07/01/2013
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.